Amgen, Inc. (NASDAQ:AMGN)

Major Biotechs Have Short Sellers Excited

The short interest data are out for the most recent settlement date, December 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs See Rising Short Interest

The short interest data are out for the most recent settlement date, December 13. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

Stocks have continued to hit all-time highs almost day after day now, and the futures were marginally higher on Tuesday. The next two weeks are the period generally considered as ...
Read Full Story »

Allergan Gets FDA Approval for Migraine Treatment

The U.S. Food and Drug Administration (FDA) on Thursday announced that it had approved ubrogepant tablets in dosages of 50 mg and 100 mg for the immediate treatment of migraine ...
Read Full Story »

Goldman Sachs Has 3 Top Health Care Stocks to Outperform in 2020

Health care remains a political hot button. Despite the Affordable Care Act, there remains a push and pull in the industry over which companies can survive and which ones can ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Adobe, Amgen, BofA, Broadcom, CME, Goldman Sachs, Micron, PepsiCo, UnitedHealth, Urban Outfitters, Vertex and More

Stocks hit all-time highs last week and a phase-one trade deal with China has been announced without details, and stocks were indicated to post a marginally higher opening price on ...
Read Full Story »

Major Biotechs See a Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, November 29. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Short Sellers Run For Cover From Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Amgen, Applied Materials, Biogen, CRISPR, CrowdStrike, CSX, Kroger, Slack, Teva, Xerox and More

Stocks were mixed in the premarket on Tuesday and the day was just looking for direction after last week's all-time highs. Investors still have a lot of pressing issues and ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amgen, Beyond Meat, Cisco, Home Depot, Microsoft, RingCentral, Shake Shack, Tilray, Uber, Under Armour, US Steel and More

Stocks were indicated to open higher again on Tuesday morning in a continued breakout to the upside. This is just a day after the Dow Jones industrials and S&P 500 ...
Read Full Story »

Why Amgen Failed to Impress in Q3

When Amgen Inc. (NASDAQ: AMGN) released its third-quarter financial results after the markets closed on Tuesday, the firm said that it had $3.66 in earnings per share (EPS) and $5.7 ...
Read Full Story »

Can Amgen Earnings Keep Up With Biogen?

Amgen Inc. (NASDAQ: AMGN) is set to report its most recent quarterly results after the closing bell on Tuesday. The consensus forecast calls for $3.53 in earnings per share (EPS) ...
Read Full Story »

Alphabet, AT&T, Facebook, Mastercard, Starbucks and More Major Earnings This Week

Now that the third-quarter earnings reporting season is has kicked off, many more major companies will be sharing their results in the coming weeks. Here, 24/7 Wall St. has put ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, October 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »